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Background. Chronicmyelogenous leukemia (CML) is characterized by tremendous amount of immaturemyeloid cells in the blood
circulation. E2F1–3 andMYC are important transcription factors that form positive feedback loops by reciprocal regulation in their
own transcription processes. Since genes regulated by E2F1–3 or MYC are related to cell proliferation and apoptosis, we wonder if
there exists difference in the coexpression patterns of genes regulated concurrently by E2F1–3 andMYCbetween the normal and the
CML states. Results. We proposed a method to explore the difference in the coexpression patterns of those candidate target genes
between the normal and the CML groups. A disease-specific cutoff point for coexpression levels that classified the coexpressed gene
pairs into strong andweak coexpression classeswas identified.Our developedmethod effectively identified the coexpression pattern
differences from the overall structure. Moreover, we found that genes related to the cell adhesion and angiogenesis properties were
more likely to be coexpressed in the normal group when compared to the CML group. Conclusion. Our findings may be helpful in
exploring the underlying mechanisms of CML and provide useful information in cancer treatment.
1. Introduction
Chronic myelogenous leukemia (CML) is a clonal myelo-
proliferative disorder that is characterized by the premature
circulation of many immature myeloid cells in the blood
stream [1]. The incidence rate of CML is about 1-2 per
100,000 per year. CML accounts for 20% of all leukemias
affecting adults with a median age of 45 to 55 years [2].
The characteristics of CML at the cellular level include
increased proliferation, increased resistance to apoptosis, and
alterations in adhesion properties of leukemic progenitors
[1]. Recently, there are many more studies on the analysis of
microarray gene expression profiles in CML. Most of them
investigate the function of differentially expressed genes such
as the study to explore the relationship between pathways and
differentially expressed genes from untreated CML patients
in the chronic phase [3]. However, few studies are available
on the coexpression analysis.
Transcription factor (TF), a kind of transacting factor,
plays the most vital role in the regulation of gene expression
and process of signal transduction [4]. E2F family of tran-
scription factors is important to control cellular proliferation
by regulating transcription of various genes involved in DNA
replication, DNA repair, mitosis, and cell cycle progression
[5]. According to structure-function studies and amino
acid sequence analysis, members of the E2F family can be
classified into two main subclasses: activators E2F1–3 and
repressors E2F4–8 [5]. The transcription activators E2F1,
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2, and 3 are vital for cell cycle progression, especially in
the G1/S transition process [6]. The protooncogene c-myc
encodes a transcription factor (MYC) that can induce both
cell proliferation and apoptosis [7]. As a transcription factor,
MYC can both activate and repress transcription of target
genes. High-throughput techniques have shown that MYC-
activated genes are involved in growth, protein synthesis,
and mitochondrial function. Most of MYC-repressed genes
participate in the interaction and communication between
cells and their external environment, and several genes are
found to have antiproliferative or antimetastatic properties
[8]. In addition, E2F1–3 and MYC are reciprocally regulated
in the transcription process to form positive feedback loops
among them [9].
Target genes regulated by the same TF tend to be
coexpressed, and the coexpression degree is increased if
genes share more TFs [10]. Moreover, coexpression analysis
has been used to study functionally related genes since
the coexpressed genes are more likely to participate in the
similar cellular processes and pathways [11]. Furthermore,
coexpressed genes are different in different states and cell
types [12]. As a result, coexpression pattern analysis is a
powerful strategy for grouping genes and further analyzing
the underlying mechanisms of diseases. The different coex-
pression pattern can be regarded as the signature of a disease.
Since target genes regulated by E2F1–3 orMYC are related
to cell proliferation and apoptosis, we wonder if there exists
difference in the coexpression patterns of genes regulated
concurrently by E2F1–3 and MYC between the normal and
the CML states. In order to answer this research question,
we proposed a method to explore the difference in the
coexpression patterns by identifying a disease-specific cutoff
point for coexpression levels that classified the coexpressed
gene pairs into strong and weak coexpression classes so
that the class was best coherent with the disease phenotype.
Traditional methods on the coexpression analysis identify
significantly coexpressed gene pairs by calculating a 𝑃 value
of correlation coefficient for each gene pair individually,
which cannot reflect the overall difference between two
different groups. Our method calculated all the correlation
coefficients in each group to form two different cumulative
distributions including all the gene pairs, which can identify
the difference between two different groups from the overall
structure. Also, the different coexpression pattern reflected
the biological alterations in CML compared to the normal
state. Annotation of the candidate target genes and mapping
the coexpressed gene pairs to the annotated gene pairs from
enriched process networks provided important information
to understand the underlying mechanisms of the CML and
the normal states.
2. Methods
2.1. Microarray Expression Data. Microarray technology is
used to monitor the expression levels of thousands of genes
in cells simultaneously [13]. Gene expression analysis across
different conditions, the normal and the disease states, may
contribute much to the exploration of disease mechanisms.
In this study, we analyzed the microarray dataset GSE5550,
normalized by variance stabilizing transformations (VSN)
method, which is publicly available on the Gene Expression
Omnibus (GEO) repository [3]. The data were obtained from
gene expression measurements of 8,537 unique mRNAs.
CD34+ hematopoietic stem and progenitor cells were col-
lected from the bonemarrow of patients with untreated CML
in the chronic phase and health controls [3]. The subjects
recruited for this dataset are Caucasians in Germany. The
CML group consisted of nine patient samples, and the control
group included eight normal samples. In this dataset, a gene
may be interrogated by more than one probe. In this case, we
took the average of all the probes for the samemRNA [14, 15].
2.2. Identification of Candidate Target Genes Regulated Con-
currently by E2F1–3 andMYC. The interactions between TFs
(E2F1, E2F2, E2F3, and MYC) and target genes (TGs) were
obtained from prediction of transcriptional regulatorymodules
(PReMod) database [16]. TF binding sites are often clustered
together, called cis-regulatory modules (CRMs). PReMod
database predicts relationships between TFs and their TGs
based on the binding affinity and conservation of CRM.
It consists of more than 100,000 computationally predicted
modules within the human genome [16]. These modules give
a description of 229 potential transcription factor families
and are the first genome-wide collection of predicted regu-
latory modules for the human genome [17]. In this study, we
called the set of TF binding predictions (TF-TG pairs) from
PReMod a molecular interaction set. This set was regarded
as the reference data. After obtaining the TGs of each TF
(E2F1, E2F2, E2F3, and MYC) individually, we identified the
common TGs of these four TFs, which were regarded as
the candidate target genes for further analysis. The flowchart
is shown in Figure S1 in Supplementary Material available
online at http://dx.doi.org/10.1155/2014/439840.
2.3. Coexpression Measure. We chose Pearson correlation
coefficient as the similarity measure. It is represented by
the direction cosine between two vectors normalized by
the subtraction of their own means, and its value accounts
for the angle between two feature vectors instead of the
vector lengths. Moreover, Pearson correlation coefficient
numerically indicates the biological relationship of two genes
but does not vary with the magnitudes of their expression
profiles [11, 18]. In general, similarity measure is a kernel
function between two feature vectors. In this study, each
feature vector consisted of the expression intensity of a gene
across all the samples in the normal group or the CML
group, respectively. The correlation coefficient of any two
genes among the candidate target genes was calculated. We
took the absolute value of correlation coefficient (|𝑟|) since the
coexpression measure output a scalar in the range from 0 to 1
where a high output indicated a strong biological relationship
in either positive or negative direction, and a low output
indicated a weak biological relationship. The coexpression
level was denoted by 𝐶𝑑(𝑖, 𝑗) if two expression profiles were
extracted from samples of the disease (CML) group and
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𝐶𝑛(𝑖, 𝑗) for the normal group, shown in Formulas (1) as
follows:
𝐶𝑑 (𝑖, 𝑗) =
󵄨󵄨󵄨󵄨󵄨
cor (𝑥𝑑𝑖, 𝑥𝑑𝑗)
󵄨󵄨󵄨󵄨󵄨
,
𝐶𝑛 (𝑖, 𝑗) =
󵄨󵄨󵄨󵄨󵄨
cor (𝑥𝑛𝑖, 𝑥𝑛𝑗)
󵄨󵄨󵄨󵄨󵄨
,
(1)
where 𝐶𝑑(𝑖, 𝑗) and 𝐶𝑛(𝑖, 𝑗) are defined as the absolute values
of correlation coefficients between the expression profiles of
genes 𝑖 and 𝑗 in the CML group and the normal group,
respectively [18]; 𝑥𝑑𝑖 and 𝑥𝑑𝑗 are the expression profiles
of the 𝑖th and 𝑗th genes in the CML group; 𝑥𝑛𝑖 and 𝑥𝑛𝑗
are the expression profiles of the 𝑖th and jth genes in the
normal group; cor(𝑥𝑑𝑖, 𝑥𝑑𝑗) and cor(𝑥𝑛𝑖, 𝑥𝑛𝑗) are the Pearson
correlation coefficients between them in the CML group and
the normal group, respectively.
2.4. Classification of Coexpressed Gene Pairs. There was a
set of correlation coefficients in either the normal group
or the CML group. The two sets of correlation coefficients
formed two cumulative distributions.We applied two-sample
Kolmogorov-Smirnov (KS) test to identify the difference in
the overall distributions of these two conditions (𝐶𝑑 and 𝐶𝑛),
including all the gene pairs.Themaximumdeviation between
two cumulative distributions of 𝐶𝑑 and 𝐶𝑛 was identified
(Formulas (2)), at which a threshold was found to classify
the coexpressed gene pairs into strong andweak coexpression
classes, called the disease-specific cutoff point (𝐶). The cutoff
point represented a coexpression level, at which 𝐹𝑑 and 𝐹𝑛
were extremely deviated. Gene pairs were further classified
into four coexpression classes: (i) strongly coexpressed gene
pairs in the normal group: pairs with coexpression levels (|𝑟|
values) bigger than or equal to 𝐶 in the normal group; (ii)
strongly coexpressed gene pairs in the CML group: pairs with
coexpression levels (|𝑟| values) bigger than or equal to𝐶 in the
CML group; (iii) weakly coexpressed gene pairs in the normal
group: pairs with coexpression levels (|𝑟| values) smaller than
𝐶 in the normal group; and (iv) weakly coexpressed gene
pairs in the CML group: pairs with coexpression levels (|𝑟|
values) smaller than 𝐶 in the CML group. Chi-square test
was used to determine if the proportions of strongly and
weakly coexpressed gene pairs significantly differed between
the normal and the CML groups
𝐷 = max
𝐶
󵄨󵄨󵄨󵄨𝐹𝑑 (𝐶) − 𝐹𝑛 (𝐶)
󵄨󵄨󵄨󵄨 ,
𝐹𝑑 (𝐶) = Prob (𝐶𝑑 ≥ 𝐶) ,
𝐹𝑛 (𝐶) = Prob (𝐶𝑛 ≥ 𝐶) ,
(2)
where 𝐹𝑑 and 𝐹𝑛 are the cumulative distribution functions
(CDFs) of 𝐶𝑑 and 𝐶𝑛, respectively; 𝐷 is the maximum
deviation; 𝐶 is the cutoff point.
We further identified the specifically coexpressed gene
pairs in different groups. Each type of gene pair represented a
particular biological meaning. The normal-specific strongly
coexpressed gene pairs were the gene pairs strongly coex-
pressed only in the normal group, which were regarded as
the potential molecular interactions maintaining physiolog-
ical balance in healthy individuals, and the impairment of
these connections may lead to diseases. Obviously, these
pairs were the CML-specific weakly coexpressed gene pairs,
which were weakly coexpressed only in the CML group. The
CML-specific strongly coexpressed gene pairs were the gene
pairs strongly coexpressed only in the CML group, which
represented the characteristics of the disease and may be
the pathogenic alternatives when the corresponding normal-
specific gene pairs cannot be coexpressed for responding to
stress. Similarly, these pairs were regarded as the normal-
specific weakly coexpressed gene pairs.
2.5. Functional Annotation for Candidate Target Genes. We
applied MetaCore from GeneGo Inc. to annotate the can-
didate target genes. Specifically, when we uploaded the
candidate target genes from Section 2.2 into this database, it
mapped these genes to a set of cellular and molecular process
networks, which are defined and annotated by Thomson
Reuters scientists. In MetaCore, each process is defined as
a preset network describing the protein interactions among
them. In each process network, the annotated target genes
were those genes included in both Section 2.2 and this process
network. Enrichment analysis for a process network inMeta-
Core is performed based on the 𝑃 value of hypergeometric
intersection between the uploaded candidate target genes and
the process-related genes in this database. The lower the 𝑃
value is obtained, the higher the relevance of this process
network to the candidate target genes and the rating of this
process network are indicated. Only the top 10 statistically
enriched process networks are shown according to the sorted
𝑃 values inMetaCore.
2.6. Mapping Coexpressed Gene Pairs to Annotated Gene
Pairs. The annotated target genes in each process network
were paired with all the possible combinations to form
the annotated gene pairs. The annotated gene pairs from
each process network were mapped to the coexpressed gene
pairs identified in Section 2.4: the normal-specific strongly
coexpressed, the normal-specific weakly coexpressed, the
CML-specific strongly coexpressed, and the CML-specific
weakly coexpressed gene pairs. We applied Fisher’s exact
test to identify if there were more mapped normal-specific
strongly coexpressed gene pairs than mapped CML-specific
strongly coexpressed gene pairs in each process network. In
other words, we planned to identify if these genes were more
likely to be coexpressed in the normal group compared to
the CML group. As a result, one-sided 𝑃 value was chosen.
False discovery rates (FDRs) are usually used to control
the expected proportion of false positives for the multiple
hypotheses. In this study, the FDRs were calculated based
on the 𝑃 values obtained from Fisher’s exact test [19]. A
process network was significantly mapped, if its FDR value
was smaller than 0.05 [20]. The FDR values were estimated
via theMatlab function,mafdr [21].
3. Results
3.1. Identification of Structural Coexpression Difference. In
total, we identified 217 common TGs of E2F1–3 and MYC
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Figure 1: Plots of distributions for coexpression analysis. (a) Cumulative distribution functions of coexpression levels in the normal and the
CML groups. (b) Deviation distribution against different coexpression cutoff points.
Table 1: The coexpressed gene pairs identified by the disease-
specific cutoff point.
Group Number of stronglycoexpressed pairs
Number of weakly
coexpressed pairs
Normal 7436 16000
CML 6083 17353
that can be found in the microarray dataset GSE5550 (Table
S1). We further extracted the available expression profiles
of these TGs and calculated the correlation coefficients in
both the normal and the CML groups. In each group, there
was a set of correlation coefficients of 23,436 gene pairs. We
plotted the cumulative distributions of these two sets of data.
The distributions between the normal and the CML groups
were significantly different (𝑃 value = 2.00 × 10−34 for 𝐷 =
0.0577). The disease-specific cutoff point that classified the
coexpressed gene pairs into strong and weak coexpression
classes was𝐶 = 0.440 (Figure 1(a)). Figure 1(b) illustrates that
the deviation was small at the two extremes, and the peak
(𝐷 = 0.0577) was found at the disease-specific cutoff point.
Two coexpression patterns were so distinct that the normal
group had more strongly coexpressed (level above ∼0.440)
and less weakly coexpressed (level below ∼0.440) gene pairs
than those in the CML group (Figure 1(a)). The cutoff point
classified the gene pairs into four coexpression classes, shown
in Table 1. The number of strongly coexpressed gene pairs in
the normal group (7436) was larger than that in the CML
group (6083). Chi-square test indicated that the proportions
of strongly and weakly coexpressed gene pairs significantly
differed between the normal and the CML groups (𝑃 value =
2.74 × 10−43 for 𝜒2 = 190).
3.2. MetaCore Analysis for Enriched Process Networks. The
top 10 statistically enriched process networks for functional
annotation of the 217 candidate target genes are shown in
Table S2. All the𝑃 values for hypergeometric intersection test
were smaller than 0.05. We got the annotated target genes
involved in each process network and mapped the annotated
gene pairs to the coexpressed gene pairs. Fisher’s exact test
was used to identify if there were more mapped normal-
specific strongly coexpressed gene pairs than mapped CML-
specific strongly coexpressed gene pairs in each process
network.The results showed that 8 out of 10 process networks
hadmoremapped normal-specific strongly coexpressed gene
pairs (Table 2). Fisher’s exact test demonstrated that “Cell
adhesion Attractive and repulsive receptors” and “Develop-
ment Regulation of angiogenesis” process networks were sig-
nificantly mapped (𝑃 values = 0.001 and 0.012, <0.05, and
FDR values were 0.004 and 0.026, <0.05).
We further plotted the coexpression networks for the
mapped normal-specific strongly coexpressed gene pairs
(a = 6 and 8) (Figure 2). Both “Cell adhesion Attractive
and repulsive receptors” and “Development Regulation of
angiogenesis” process networks had ephrin-B2 (EFNB2),
ephrin-A5 (EFNA5), and EPH receptor A4 (EPHA4) (Figure
S2). From National Center for Biotechnology Information
(NCBI) database, we obtained the basic information for these
genes/proteins. EFNB2 and EFNA5 are the members of the
ephrin gene family. EPHA4 protein product is an ephrin
receptor. The ephrins (EPH) and EPH-related receptors
belong to the largest subfamily of receptor protein-tyrosine
kinases, which play a vital role in mediating developmental
events. Figure 2 shows that the connection from EFNA5
to EPHA4 was identified as a strongly coexpressed gene
pair for these two process networks in the normal group.
In addition, protein products from neuropilin 2 (NRP2),
transforming growth factor, beta receptor II (TGFBR2), and
somatostatin receptor 2 (SSTR2) also belong to receptors,
which are very important in signal transduction process. The
encoded protein from integrin, alpha 2 (ITGA2), plays a vital
BioMed Research International 5
Table 2: Mapping coexpressed gene pairs to annotated gene pairs from each process network.
Process networks Fisher’s exact test FDR
𝑎 𝑏 𝑐 𝑑 𝑃 value
Development Neurogenesis in general 14 11 11 14 0.286 0.251
Development Hedgehog signaling 22 15 15 22 0.081 0.118
Signal transduction WNT signaling 10 7 7 10 0.247 0.270
Signal transduction TGF-beta, GDF, and activin signaling 6 5 5 6 0.500 0.365
Cell adhesion Attractive and repulsive receptors 6 0 0 6 0.001 0.004
Development Regulation of angiogenesis 8 2 2 8 0.012 0.026
Cardiac development BMP TGF beta signaling 2 1 1 2 0.500 0.313
Neurophysiological process Melatonin signaling 3 2 2 3 0.500 0.274
𝑎: mapped normal-specific strongly coexpressed gene pairs; 𝑏: mapped normal-specific weakly coexpressed gene pairs; 𝑐: mapped CML-specific strongly
coexpressed gene pairs; 𝑑: mapped CML-specific weakly coexpressed gene pairs.
role in leukocyte intercellular adhesion process. There were
three enzymes identified in the coexpression networks: (i)
the protein encoded by protein kinase, cAMP-dependent,
catalytic, beta (PRKACB) is a protein kinase; (ii) the protein
product from prolyl endopeptidase (PREP) is a protease; and
(iii) the protein encoded by HIV-1 Tat interactive protein 2
(HTATIP2) is an oxidoreductase required for tumor suppres-
sion. From the results, we can infer that these genes/proteins
were well connected with each other to transduce signals and
maintain physiological balance in healthy individuals. How-
ever, in the CML group, these connections were impaired.
4. Discussion and Conclusion
In this study, our developed method successfully identified
the difference in the coexpression patterns of those candidate
target genes regulated concurrently by E2F1–3 and MYC
between the normal and the CML groups from the overall
structure (Figure 1). We further found that genes involved
in the cell adhesion and angiogenesis properties were more
likely to be coexpressed in the normal group compared to
the CML group (Table 2 and Figure 2). The alteration in
adhesion properties of leukemic progenitors is one CML
characteristic at the cellular level [1]. In addition, Bhatia et al.
hypothesized that decreased integrin-mediated adhesion of
CML progenitors to stroma can lead to continuous cell
proliferation [22]. They treated the cells with interferon-𝛼
(IFN-𝛼). The results showed that the treatment restored the
CML progenitor adhesion to stroma and also the regulation
of CML progenitor proliferation [22]. Angiogenesis is the
process forming new blood from the preexisting vasculature,
including degradation of extracellularmatrix proteins, as well
as activation, proliferation, and migration of endothelial cells
[23]. In leukemia, hematopoietic cells are supported from
the normal vascular bed in bone marrow [23]. Increased
vascularity was found in acute myeloid leukemia (AML)
patients [24]. Importantly, in CML, the number of blood
vessels and vascular areas were found to be increased
when compared to control bone marrows [23]. Our results
showed that the connection from EFNA5 to EPHA4 was
identified as a strongly coexpressed gene pair in the normal
group (|𝑟| values were 0.720 and 0.013 in the normal group
and the CML group, resp.) (Figure 2). Ephrin-A recep-
tors belong to the largest subfamily of receptor tyrosine
kinases that regulate cell shape, mobility, and attachment
[25]. Interactions between Ephrin-A receptors and ligands
are important in cell-cell communication, initiating unique
bidirectional signaling cascades to transduce the information
[26]. There may be some relationships between adhesion
property and angiogenesis. These two process networks
were found to be well controlled in the normal group
compared to the CML group. Dysregulation of adhesion
and angiogenesis properties is a possible reason leading to
CML.
The advantage of our study is the application of coexpres-
sion analysis to target genes regulated concurrently by more
than one transcription factor under different conditions.
We identified different coexpression patterns between the
normal and the CML groups. A limitation for differential
expression analysis is that it only reflects the upregulation or
downregulation of existing components in the well-known
pathways under the normal or the disease condition, which
cannot identify the functionally associated linkages among
genes during signal transduction. In addition, differential
expression analysis does not take account of the level of
correlations that may exist between gene expression pat-
terns [12]. Coexpression analysis is useful for analyzing the
underlying mechanisms of diseases. Moreover, the different
coexpression pattern can be regarded as the signature of
a disease.
Several methods have been proposed to analyze coex-
pressed genes. The two-stage screening procedure was
applied to select statistically and biologically significant gene
pairs in Zhu et al.’s study [27]. Gupta et al. proposed amethod
for determining the correlation threshold using the clustering
coefficient. 𝑅2 metric was used as a measure of similarity
between two genes [28]. Previous studies cannot reflect the
overall difference between two different groups. Our method
calculated all the correlation coefficients in each group (the
normal group and the CML group) to form two distributions,
which can find the difference between two different groups
from the overall structure.
In summary, we have presented a detailed method to
identify a disease-specific cutoff point for coexpression levels
6 BioMed Research International
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Figure 2: Coexpression networks for the mapped normal-specific strongly coexpressed gene pairs. The yellow ellipses are those genes
found in both process networks. (a) Mapped normal-specific strongly coexpressed gene pairs in the “Cell adhesion Attractive and repulsive
receptors” process network. (b) Mapped normal-specific strongly coexpressed gene pairs in the “Development Regulation of angiogenesis”
process network.
that classified the coexpressed gene pairs into strong and
weak coexpression classes so that the class was best coherent
with the disease phenotype. We applied this method to
explore the difference in the coexpression patterns of target
genes regulated concurrently by E2F1–3 and MYC between
the normal and the CML groups. Our method effectively
identified the statistical differences between the normal and
the CML groups from the overall structure. We further
found the potentially altered cell adhesion and angiogenesis
properties in the CML state when compared to the normal
group. The different coexpression pattern can reflect the
biological alterations in CML. Our significant findings will
be helpful in exploring the underlying mechanisms of CML
and provide useful information in cancer treatment.
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